Cardiovascular Drugs Market Research Reports

Global Cardiovascular Disease Drugs Market to 2023 - Expiries, Acquisitions and New Products for Deep Vein Thrombosis, Pulmonary Arterial Hypertension and Dyslipidemia to Shake-Up the Competitive Landscape - Product Thumbnail Image

Global Cardiovascular Disease Drugs Market to 2023 - Expiries, Acquisitions and New Products for Deep Vein Thrombosis, Pulmonary Arterial Hypertension and Dyslipidemia to Shake-Up the Competitive Landscape

  • Report
  • 228 Pages
From
Anticoagulants - Global Strategic Business Report - Product Thumbnail Image

Anticoagulants - Global Strategic Business Report

  • Report
  • 285 Pages
From
Frontier Pharma: Type 2 Diabetes Mellitus - Therapies Targeting GPCRs and Protein Kinases Dominate Pipeline, with Strong Repositioning Opportunities into Associated Areas, Including Obesity and Cardiovascular Disease - Product Thumbnail Image

Frontier Pharma: Type 2 Diabetes Mellitus - Therapies Targeting GPCRs and Protein Kinases Dominate Pipeline, with Strong Repositioning Opportunities into Associated Areas, Including Obesity and Cardiovascular Disease

  • Report
  • 77 Pages
From
Frontier Pharma: Cardiovascular Disease - Diverse First-in-Class Molecular Targets to Bridge Unmet Needs in Pulmonary Hypertension, Heart Failure and Atherosclerosis - Product Thumbnail Image

Frontier Pharma: Cardiovascular Disease - Diverse First-in-Class Molecular Targets to Bridge Unmet Needs in Pulmonary Hypertension, Heart Failure and Atherosclerosis

  • Report
  • 113 Pages
From
Indian Peptides and Heparin Market by Type (Insulin, Teriparatide, Liraglutide, Leuprolide, Leuprolide, Exenatide, Calcitonin, Enaxaparin Sodium, Heparin Sodium), Application (Diabetes, Infectious Diseases, Cancer, Osteoporosis) - Forecast to 2022 - Product Thumbnail Image

Indian Peptides and Heparin Market by Type (Insulin, Teriparatide, Liraglutide, Leuprolide, Leuprolide, Exenatide, Calcitonin, Enaxaparin Sodium, Heparin Sodium), Application (Diabetes, Infectious Diseases, Cancer, Osteoporosis) - Forecast to 2022

  • Report
  • 77 Pages
From
Cardiovascular Drugs: Global Markets to 2022 - Product Thumbnail Image

Cardiovascular Drugs: Global Markets to 2022

  • Report
  • 174 Pages
From
Global Heart Failure Drugs Market 2018-2022 - Product Thumbnail Image

Global Heart Failure Drugs Market 2018-2022

  • Report
  • 113 Pages
From
Global Vasculitis Market Research and Forecast 2018-2023 - Product Thumbnail Image

Global Vasculitis Market Research and Forecast 2018-2023

  • Report
From
Global Cardiovascular Partnering 2012-2018: Deal trends, players and financials - Product Thumbnail Image

Global Cardiovascular Partnering 2012-2018: Deal trends, players and financials

  • Report
  • 500 Pages
From
Global Angina Pectoris Drugs Market 2017-2021 - Product Thumbnail Image

Global Angina Pectoris Drugs Market 2017-2021

  • Report
  • 82 Pages
From
Global Coronary Artery Disease Therapeutics Market 2017-2021 - Product Thumbnail Image

Global Coronary Artery Disease Therapeutics Market 2017-2021

  • Report
  • 100 Pages
From
Global Respiratory Complications Therapeutics Market to 2022 - Innovative Pneumonia and Pulmonary Arterial Hypertension Therapies Dominate Varied Disease Market - Product Thumbnail Image

Global Respiratory Complications Therapeutics Market to 2022 - Innovative Pneumonia and Pulmonary Arterial Hypertension Therapies Dominate Varied Disease Market

  • Report
  • 197 Pages
From
Anti-hypertensive Therapeutics in Asia-Pacific Markets to 2022 - Increasing Prevalence of Hypertension Drives Market Growth despite Weak Pipeline - Product Thumbnail Image

Anti-hypertensive Therapeutics in Asia-Pacific Markets to 2022 - Increasing Prevalence of Hypertension Drives Market Growth despite Weak Pipeline

  • Report
  • 110 Pages
From
Dyslipidaemia Forecast in 12 Major Markets 2017-2027 - Product Thumbnail Image

Dyslipidaemia Forecast in 12 Major Markets 2017-2027

  • Report
  • 58 Pages
From
Cardiovascular Disorders Drug Development Pipeline Review, 2017 - Product Thumbnail Image

Cardiovascular Disorders Drug Development Pipeline Review, 2017

  • Report
  • 432 Pages
From
Global Cardiovascular Disease Market to 2022 - Sanofi and Novartis to Become Market Leaders as Praluent and Entresto Drive Revenue Growth - Product Thumbnail Image

Global Cardiovascular Disease Market to 2022 - Sanofi and Novartis to Become Market Leaders as Praluent and Entresto Drive Revenue Growth

  • Report
  • 192 Pages
From
Acute Heart Failure (AHF) Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Acute Heart Failure (AHF) Therapeutics - Global Strategic Business Report

  • Report
  • 156 Pages
From
Hypertension Forecast in 12 Major Markets 2016-2026 - Product Thumbnail Image

Hypertension Forecast in 12 Major Markets 2016-2026

  • Report
  • 56 Pages
From
Peripheral Arterial Disease (PAD) Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Peripheral Arterial Disease (PAD) Therapeutics - Global Strategic Business Report

  • Report
  • 136 Pages
From
Pulmonary Arterial Hypertension (PAH) Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Pulmonary Arterial Hypertension (PAH) Therapeutics - Global Strategic Business Report

  • Report
  • 161 Pages
From
Loading Indicator
adroll